Company Filing History:
1 out of 753 
1 out of 4 Years Active: 2016
Title: Barbara Lee Waszczak: Innovator in Central Nervous System Treatments
Introduction
Barbara Lee Waszczak is a prominent inventor based in Wellesley, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of central nervous system (CNS) disorders. Her innovative work focuses on the use of nucleic acid nanoparticles for therapeutic purposes.
Latest Patents
Barbara Lee Waszczak holds 1 patent for her groundbreaking invention titled "Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders." This patent discloses methods and compositions aimed at treating diseases of the CNS using nucleic acid nanoparticles. Notably, her work addresses conditions such as Parkinson's Disease and includes methods for intranasally administering these nanoparticles for therapeutic effects in the brain.
Career Highlights
Throughout her career, Barbara has worked with esteemed institutions, including Northeastern University and Copernicus Therapeutics, Inc. Her research has paved the way for new treatment methodologies that could significantly impact patients suffering from CNS disorders.
Collaborations
Barbara has collaborated with notable professionals in her field, including Brendan Harmon and Mark J Cooper. These partnerships have enhanced her research and contributed to the advancement of her innovative approaches.
Conclusion
Barbara Lee Waszczak's contributions to the field of CNS treatment through her innovative use of nucleic acid nanoparticles exemplify her dedication to improving medical therapies. Her work continues to inspire advancements in the treatment of neurological disorders.